Advertisement
Review| Volume 43, ISSUE 12, P2248-2256, December 2017

Second generation of familial nonmedullary thyroid carcinoma: A meta-analysis on the clinicopathologic features and prognosis

Published:September 12, 2017DOI:https://doi.org/10.1016/j.ejso.2017.09.005

      Abstract

      Whether the second generation of parent/offspring type familial nonmedullary thyroid carcinoma (FNMTC) is more aggressive and has worse prognosis than their first generation counterpart is controversial. To evaluate the clinicopathologic features and prognosis of the second generation via a comparison between the two groups, We searched three databases (PubMed, EMBASE and the Cochrane library) to review studies published before November 25, 2016. All original studies comparing the clinicopathologic features and prognosis in the first generation of parent/offspring type FNMTC with its second generation counterpart were included. The Q-test and I2 test were used to evaluate homogeneity and funnel plot with Egger's test was used to evaluate publication bias. 6 studies, including 424 subjects were included. There was significant difference between the first and second generation of parent/offspring type FNMTC in the age of onset (SMD = −1.20, 95% CI: −2.38, −0.03, p = 0.045), gender distribution (OR = 0.48, 95% CI: 0.25, 0.90, p = 0.022) and lymph node metastasis (OR = 1.84, 95%CI: 1.16, 2.92, p = 0.01), while no significant difference in other variables. Thus we conclude that the second generation of parent/offspring type FNMTC patients is in higher risk than their first generation counterpart. We believe continuous study is needed to confirm the result.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hemminki K.
        • Li X.
        Familial risk of cancer by site and histopathology.
        Int J cancer. 2003; 103: 105-109
        • Alsanea O.
        • Wada N.
        • Ain K.
        • Wong M.
        • Taylor K.
        • Ituarte P.H.
        • et al.
        Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
        Surgery. 2000; 128 (discussion 50–51): 1043-1050
        • Mazeh H.
        • Benavidez J.
        • Poehls J.L.
        • Youngwirth L.
        • Chen H.
        • Sippel R.S.
        In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
        Thyroid Off J Am Thyroid Assoc. 2012; 22: 3-8
        • Uchino S.
        • Noguchi S.
        • Kawamoto H.
        • Yamashita H.
        • Watanabe S.
        • Yamashita H.
        • et al.
        Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
        World J Surg. 2002; 26: 897-902
        • Lee Y.M.
        • Yoon J.H.
        • Yi O.
        • Sung T.Y.
        • Chung K.W.
        • Kim W.B.
        • et al.
        Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
        J Surg Oncol. 2014; 109: 168-173
        • McDonald T.J.
        • Driedger A.A.
        • Garcia B.M.
        • Van Uum S.H.
        • Rachinsky I.
        • Chevendra V.
        • et al.
        Familial papillary thyroid carcinoma: a retrospective analysis.
        J Oncol. 2011; 2011948786
        • Pal T.
        • Vogl F.D.
        • Chappuis P.O.
        • Tsang R.
        • Brierley J.
        • Renard H.
        • et al.
        Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.
        J Clin Endocrinol Metabol. 2001; 86: 5307-5312
        • Robinson D.W.
        • Orr T.G.
        Carcinoma of the thyroid and other diseases of the thyroid in identical twins.
        AMA Archiv Surg. 1955; 70: 923-928
        • Grossman R.F.
        • Tu S.H.
        • Duh Q.Y.
        • Siperstein A.E.
        • Novosolov F.
        • Clark O.H.
        Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment.
        Archiv Surg (Chicago, Ill 1960). 1995; 130 (discussion 8–897): 892-897
        • Moses W.
        • Weng J.
        • Kebebew E.
        Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
        Thyroid Off J Am Thyroid Assoc. 2011; 21: 367-371
        • Stoffer S.S.
        • Van Dyke D.L.
        • Bach J.V.
        • Szpunar W.
        • Weiss L.
        Familial papillary carcinoma of the thyroid.
        Am J Med Genet. 1986; 25: 775-782
        • Sturgeon C.
        • Clark O.H.
        Familial nonmedullary thyroid cancer.
        Thyroid Off J Am Thyroid Assoc. 2005; 15: 588-593
        • Cao J.
        • Chen C.
        • Chen C.
        • Wang Q.L.
        • Ge M.H.
        Clinicopathological features and prognosis of familial papillary thyroid carcinoma - a large-scale, matched, case-control study.
        Clin Endocrinol. 2016; 84: 598-606
        • Capezzone M.
        • Marchisotta S.
        • Cantara S.
        • Busonero G.
        • Brilli L.
        • Pazaitou-Panayiotou K.
        • et al.
        Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
        Endocrine Related Cancer. 2008; 15: 1075-1081
        • Hillenbrand A.
        • Varhaug J.E.
        • Brauckhoff M.
        • Pandev R.
        • Haufe S.
        • Dotzenrath C.
        • et al.
        Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study : ESES Vienna presentation.
        Langenbeck's Archiv Surg. 2010; 395: 851-858
        • Park Y.J.
        • Ahn H.Y.
        • Choi H.S.
        • Kim K.W.
        • Park D.J.
        • Cho B.Y.
        The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.
        Thyroid Off J Am Thyroid Assoc. 2012; 22: 356-362
        • Lei S.
        • Wang D.
        • Ge J.
        • Liu H.
        • Zhao D.
        • Li G.
        • et al.
        Single-center study of familial papillary thyroid cancer in China: surgical considerations.
        World J Surg Oncol. 2015; 13: 115
        • Robenshtok E.
        • Tzvetov G.
        • Grozinsky-Glasberg S.
        • Shraga-Slutzky I.
        • Weinstein R.
        • Lazar L.
        • et al.
        Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
        Thyroid Off J Am Thyroid Assoc. 2011; 21: 43-48
        • Wells G.A.S.B.
        • O'Connell D.
        • Peterson J.
        • Welch V.
        • Losos M.
        • Tugwell P.
        The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
        ([webpage on the Internet]) Ottawa Hospital Research Institute, 2011 (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp)
        • Higgins J.P.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Harbord R.M.
        • Egger M.
        • Sterne J.A.
        A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.
        Stat Med. 2006; 25: 3443-3457
        • Egger M.
        • Davey Smith G.
        • Schneider M.
        • Minder C.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ (Clinical research ed.). 1997; 315: 629-634
        • Rego-Iraeta A.
        • Perez-Mendez L.F.
        • Mantinan B.
        • Garcia-Mayor R.V.
        Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.
        Thyroid Off J Am Thyroid Assoc. 2009; 19: 333-340
        • McLeod D.S.
        • Sawka A.M.
        • Cooper D.S.
        Controversies in primary treatment of low-risk papillary thyroid cancer.
        Lancet (London, England). 2013; 381: 1046-1057
        • Leenhardt L.
        • Grosclaude P.
        • Cherie-Challine L.
        Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.
        Thyroid Off J Am Thyroid Assoc. 2004; 14: 1056-1060
        • Pinto A.E.
        • Silva G.L.
        • Henrique R.
        • Menezes F.D.
        • Teixeira M.R.
        • Leite V.
        Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.
        Eur J Endocrinol. 2014; 170: 321-327
        • Larsen K.
        • Petersen J.
        • Bernstein I.
        • Nilbert M.
        A parametric model for analyzing anticipation in genetically predisposed families.
        Stat Appl Genet Mol Biol. 2009; 8 (Article26)
        • Khara L.
        • Silverman A.
        • Bethel C.
        • D'Cruz C.
        • Sun X.
        Thyroid papillary carcinoma in a 3-year-old American boy with a family history of thyroid cancer: a case report and literature review.
        J Pediatr Hematol Oncol. 2010; 32: e118-e121
        • Mulligan L.M.
        • Marsh D.J.
        • Robinson B.G.
        • Schuffenecker I.
        • Zedenius J.
        • Lips C.J.
        • et al.
        Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.
        J Intern Med. 1995; 238: 343-346
        • Charkes N.D.
        On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.
        Thyroid Off J Am Thyroid Assoc. 2006; 16: 181-186
        • Groden J.
        • Thliveris A.
        • Samowitz W.
        • Carlson M.
        • Gelbert L.
        • Albertsen H.
        • et al.
        Identification and characterization of the familial adenomatous polyposis coli gene.
        Cell. 1991; 66: 589-600
        • Lenoir G.M.
        • Lynch H.
        • Watson P.
        • Conway T.
        • Lynch J.
        • Narod S.
        • et al.
        Familial breast-ovarian cancer locus on chromosome 17q12-q23.
        Lancet. 1991; 338: 82-83